Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:26:11.389Z.
Consensus retrieved: 2026-10-06T09:36:21.484Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:26:11.389Z.
Quote observation: 2026-10-06T15:19:36.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dd458a7b7530169a13c79e175a6610edc18df904cb2af71895118b3708428af2
Forward PE Ratio (N/A) = Dated Quote Price ($2.58) / Consensus Forward EPS ($-2.53)
FORWARD PE RATIO
N/A
Boundless Bio, Inc.
Market Cap
$57.98M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Boundless Bio, Inc. (BOLD) | $57.98M | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.99M | N/A |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $59.23M | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $60.12M | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.15M | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.17M | N/A |
| Spectral AI, Inc. (MDAI)vs › | $55.21M | N/A |
| Adicet Bio, Inc. (ACET)vs › | $60.92M | N/A |
| Aldeyra The (ALDX)vs › | $54.90M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $2.58, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-2.53 | $-2.53 – $-2.53 | 1 | n/m |
| 2027-12-31 | $-0.98 | $-0.98 – $-0.98 | 1 | n/m |
| 2028-12-31 | $-1.56 | $-1.56 – $-1.56 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
